Tuesday 25102016 1011 40 MCQs Location 102 105 106 301 302 The Behavior of Proteins Enzymes Mechanisms and Control General theory of enzyme action by ID: 780718
Download The PPT/PDF document "FIRST BIOCHEMISTRY EXAM" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
FIRST BIOCHEMISTRY EXAM
Tuesday 25/10/2016
10-11
40 MCQs.
Location : 102, 105, 106, 301, 302
Slide2The Behavior of Proteins: Enzymes,
Mechanisms, and Control
Slide3General theory of enzyme action, by
Leonor
Michaelis
and Maud
Menten in 1913.
Leonor
Michaelis
, German1875–1949
Maud
Menten
, Canadian
1879–1960
Slide4Learning Objectives
1.
What Is the
Michaelis–Menten
Approach to Enzyme
Kinetics?
2. How Do Enzymatic Reactions Respond to Inhibitors?3. Does the Michaelis–Menten Model Describe the Behavior of
Allosteric Enzymes ? 4. What Are the Models for the Behavior of Allosteric Enzymes?
5. What is
Lineweaver
–Burk plot ?
5 . How Does
Phosphorylation
of Specific Residues Regulate
Enzyme Activity?
6. What Are Zymogens, and How Do They Control Enzyme Activity?
7. What Are Coenzymes and Cofactors ?
8. What Are
Isoenzymes
& what is their clinical application.
Slide5They postulated that the enzyme first combines reversibly with its substrate to form an enzyme-substrate complex in a relatively fast reversible step:
The ES complex then breaks down in a slower second step to yield the free enzyme and the reaction product P:
Slide6Slide7Michaelis-Menten Model
2
V
max
[S]
V
=
K
M
+ [S]
Michaelis-Menten
equation
Slide8Michaelis-Menten Model
When [S]= K
M
, the equation reduces to
2
Slide9Michaelis-Menten Model
It
is difficult to determine
V
max experimentally
The equation for a hyperbola (E saturation curve)
Can be transformed into the equation for a straight line by taking the reciprocal of each side
Slide10The physiological consequence of
K
M
is illustrated by the sensitivity of some individuals to
ethanol
. Such persons exhibit facial flushing and rapid heart rate (tachycardia) after ingesting even small amounts of alcohol.In the liver, alcohol
dehydrogenase converts ethanol into acetaldehyde
Slide11Normally, the acetaldehyde, which is the cause of the symptoms when present at high concentrations, is processed to acetate by acetaldehyde
dehydrogenase
.
Slide12Most people have two forms of the acetaldehyde
dehydrogenase
,
a low
K
M mitochondrial form and a high KM
cytosolic
form. In susceptible persons, the mitochondrial enzyme is less active due to the substitution of a single amino acid, and acetaldehyde is processed only by the cytosolic enzyme. Because this enzyme has a high K
M
, less acetaldehyde is
converted into acetate; excess
acetaldehyde
escapes into the blood and accounts for the physiological effects.
Slide13Lineweaver
-Burk Plot
which has the form y =
mx
+ b, and is the formula for a straight line (
linearization)
a plot of 1/V versus 1/[S] will give a straight line with slope of KM/
Vmax and y intercept of 1/Vmaxsuch a plot is known as a Lineweaver
-Burk double reciprocal
plot
Slide14Lineweaver
-Burk Plot
K
M
is the dissociation constant for ES; the
greater
the value of KM
, the less tightly S is bound (less affinity) to E
The
units K
M
are units of [S] that is M or
mM
Slide15Turnover number
Turnover number (
k
cat
): is the moles of
S converted to P per mole of
E per second.Unit of k
cat is mol S*mol E-1*s-1
The higher
K
cat
value the higher the reactivity of the E
Slide16Turnover Numbers and K
M
Values for some typical enzymes
Enzyme
Function
Catalase
C
onversion of
H
2
O
2
to H
2
O + O
2
4 x 10
7
25
Carbonic
anhydrase
Hydration of CO
2
1 x 10
6
12
Acetylcholin-
esterase
Regeneration
of acetylcholine
1.4 x 10
4
9.5 x 10
-2
Chymotrypsin
Proteolytic enzyme
1.9.x 10
2
6.6 x 10
-1
Lysozyme
Hydrolysis of
bacterial cell wall
polysaccharides
0.5
6 x 10
-3
K
M
(mmol•liter
-1
)
Turnover numbr
[(mol S)•(mol E)
-1
•s
-1
]
Slide17Enzyme Inhibition
Reversible inhibitor
:
a substance that binds to an enzyme to inhibit it, but can be released
competitive inhibitor
:
binds to the active (catalytic) site and blocks access to it by substrate
noncompetitive inhibitor:
binds to a site other than the active site; inhibits the enzyme by changing its conformation
Irreversible inhibitor
:
a substance that causes inhibition that cannot be reversed
usually involves formation or breaking of covalent bonds to or on the enzyme
Cyanides, Penicillin, Heavy metals, Nerve gas
Slide18competitive inhibitor
A competitive inhibitor diminishes the rate of
catalysis by reducing the proportion of enzyme molecules bound to a substrate. At any given inhibitor concentration,
competitive inhibition can be relieved by increasing the substrate concentration. Under these conditions, the substrate "outcompetes" the inhibitor for the active site.
Slide19Methotrexate
is a structural analog of
tetrahydrofolate
, a coenzyme for the enzyme
dihydrofolate reductase, which plays a role in the biosynthesis of purines
and pyrimidines . It binds to dihydrofolate
reductase 1000-fold more tightly than the natural substrate and inhibits nucleotide base synthesis. It is used to treat cancer.
Slide20The cofactor
tetrahydrofolate
and its structural analog
methotrexate
. Regions with
structural differences are shown in red.
Slide21noncompetitive inhibitor
In
noncompetitive inhibition, which also is reversible, the inhibitor and substrate can bind simultaneously to an enzyme
molecule at different binding sites . A noncompetitive inhibitor acts by decreasing the turnover number rather than by diminishing the proportion of enzyme molecules that are bound to substrate. Noncompetitive inhibition, in
contrast with competitive inhibition, cannot be overcome by increasing the substrate concentration.
Competitive
Vs
noncompetitive Inhibition
Slide23Competitive Inhibition Illustrated on a Double-Reciprocal Plot. A double-reciprocal plot of enzyme kinetics in the presence
( I )
and absence ( I ) of a competitive inhibitor illustrates that the inhibitor has no effect on
V max
but increases
K M.
Slide24Noncompetitive Inhibition
Illustrated on a Double-Reciprocal Plot. A double-reciprocal plot of enzyme kinetics in the presence
( I )
and absence ( I ) of a noncompetitive inhibitor shows that
K M
is unaltered and
V max
is decreased.
Slide25Irreversible inhibitor
Penicillin acts by covalently modifying the enzyme
transpeptidase
, thereby preventing the synthesis of bacterial cell walls and thus killing the bacteria .
Aspirin acts by covalently modifying the
enzyme
cyclooxygenase, reducing the synthesis of inflammatory signals.
Slide26Structure of Penicillin
Formation of a
Penicilloyl
-Enzyme Complex.
Slide27Chymotrypsin
Inhibition
Treatment with
organofluorophosphates
such as
diisopropylphosphofluoridate
(DIPF) was found to inactivate the enzyme irreversibly .Despite the fact that the enzyme possesses 28 serine residues, only one, serine 195
, was modified, resulting in a total loss of enzyme activity. This chemical modification reaction suggested that this unusually reactive serine residue plays a central role in the catalytic mechanism of chymotrypsin.
Slide28An Unusually Reactive Serine in
Chymotrypsin
.
Chymotrypsin
is inactivated by treatment with
diisopropylphosphofluoridate
(DIPF), which reacts only with serine 195 among 28 possible serine residues
Slide29Enzyme regulation
Enzyme activity can be regulated by several ways:
Covalent modification (
Phosphorylation
)
The
side chain -OH groups of Ser,
Thr
, and Tyr can form phosphate esters
phosphorylation
by ATP
can convert an inactive precursor into an active enzyme
Protein
kinases
phosphorylate
enzymes
Protein
phosphatases
remove phosphate groups
Slide30Enzyme regulation
Covalent modification (
Phosphorylation
)
Slide31Noncovalent
modification (
Allosteric
regulation)
Using
allosteric
effectors (activator and
allosteric inhibitor )
Control amount of enzyme:
enzyme synthesis: gene regulation
enzyme degradation
Slide32Zymogen
: an inactive precursor of an enzyme; cleavage of one or more covalent bonds transforms it into the active enzyme
Involved in blood clotting and digestion
Example
chymotrypsinogen
Chymotrypsinogen
synthesized and stored in the pancreasa single polypeptide chain of 245 amino acid residues cross linked by five disulfide (-S-S-) bondsenzyme trypsin
cleaves
it to give
chymotrypsin
Slide33Secretion of Zymogens by an
Acinar
Cell of the Pancreas
Slide34Proteolytic
Activation of
Chymotrypsinogen
. The three chains of
α
-chymotrypsin are linked by two interchain disulfide bonds
Slide35Zymogen
Activation by
Proteolytic
Cleavage
Active enzymes are shown in yellow
Slide36Blood-Clotting Cascade
Slide37Many Enzymes Require Cofactors for Activity
Slide38COENZYMES
……
Cofactors
Slide39Enzyme cofactors
Metal
Enzyme
Zn2+
Carbonic
anhydrase
Zn2+
Carboxypeptidase
Mg2+
Hexokinase
Ni2+
Urease
Se
Glutathione
peroxidase
Mn2+
Superoxide dismutase
Cu2
Cytochrome
oxidase
Slide40ISOENZYMES
Isozymes
or
isoenzymes
, are enzymes that differ in amino acid sequence yet catalyze the same reaction. Usually, these
enzymes display different kinetic parameters, such as K M, or different regulatory properties.
They are encoded by different genetic loci, which usually arise through gene duplication and divergence.
Slide41ISOENZYMES
The existence of
isozymes
permits the fine-tuning of metabolism to meet the particular needs of a given tissue or developmental stage. Consider the example of lactate
dehydrogenase
(
LDH), an enzyme that functions in anaerobic glucose metabolism and glucose synthesis. Human beings have two isozymic
polypeptide chains for this enzyme: the H isozyme highly expressed in heart and the M
isozyme
found in
skeletal muscle
. The amino acid sequences are 75% identical.
Slide42The functional enzyme is
tetrameric
, and many different combinations of the two subunits are possible. The
H4
isozyme, found in the heart, has a higher affinity for substrates than does the M4 isozyme
. The two isozymes also differin that high levels of pyruvate
allosterically inhibit the H4 but not the M4 isozyme. The other combinations, such as H3M, have intermediate properties depending on the ratio of the two kinds of chains.
Slide43ISOENZYMES……… LDH
Slide44Slide45END
Chapter 7